About
As the European medical devices regulations (MDR) enters its third year of application, the industry is striving to comply with MDR compliance in a challenging economic and regulatory environment.
As first movers approach their recertification dates, other companies are achieving their initial product and quality system certifications, while some industry players are still in the application phase to meet the transitional requirements.
At the same time, the regulatory system is scrutinised to see how it delivers on its promises of better regulation, less burdensome requirements, and competitiveness and attractiveness in a global perspective.
This year’s MedDev Day will focus on the attractiveness of the European regulatory landscape for medical devices, improvements made and future developments.
Delegates will get practical insights on:
- how to meet MDR requirements and cost of compliance,
- the comparison of the European system to other regulatory regimes and global regulatory and clinical strategy
- how to streamline and cost effectively meet post market obligations
- how to achieve recertifications in a least burdensome approach
- how to minimize efforts for phasing out MDD/AIMDD and how to successfully shift to MDR as for transition delegates
- latest developments on the regulation, EUDAMED and clinical standards
The one-and-a-half-day program features Industry and competent authority talks followed by interactive workshops to allow elaborate solutions for post market programs and clinical strategy.
Scientific Board:
Bassil Akra, Chief Executive Officer at AKRA TEAM
Arkan Zwick, Corporate Director Regulatory Affairs at CROMA Pharma
Who should attend?
The conference is aimed at medical device professionals from Regulatory Affairs, Quality, Clinical Operations, Medical Affairs, Post Marketing Surveillance departments working in Pharmaceutical, Biotechnology and Medical Device companies, CROs, Universities/Hospitals, Academic Research, Patient Associations and Healthcare Organisations, Competent Authorities, EU Commission and Regulatory Authorities.
Programme
07 October 2024 from 13:00 to 17:00
08 October 2024 from 8:30 to 17:00
Programme work in progress. Timetables subject to change.
Speakers
Bassil Akra
Dr. Bassil Akra is CEO and Owner of AKRA TEAM GmbH, a consultancy company which was founded in 2021 to support the various stakeholders in the healthcare system achieving their target in a highly regulated business area. He spent the last year consulting and supporting medical device, in-vitro diagnostic, combination device companies preparing their strategy for the EU regulations MDR 2017/745 and IVDR 2017/746. Before that, he spent many years as a subject matter expert at the biggest notified body in Europe acting in the various roles and representing locally and globally the notified body association in the various European discussion and guidance documents preparation. Dr. Akra was the Vice President of Strategic Business Development at the Global Medical Health Services of TÜV SÜD Product Service GmbH. He has long experience in leadership, business management, research, development, quality management, and regulatory approval of medical devices, combination devices, and ATMP Products. Dr. Akra played an essential role during the implementation of the medical device regulation in Europe. He was also involved in the drafting of several European guidance documents (e.g. MEDDEV, MDCG, etc.) and International Standard. He spent the last years of his career at TÜV SÜD training and educating the various stakeholders on the EU Legislations (e.g. MDD/AIMDD, MDR and IVDR), supporting their implementation towards achieving the relevant designation ensuring continuity of the healthcare system in the interest of the patient population.
Arkan Zwick
Arkan has a master’s degree in law and PhD in European law. His role includes regulatory strategy, advice and advocacy for drug, devices, and combinations product projects as well as in house legal advice for contract management and due diligence projects. His responsibility includes global regulatory compliance and regulatory market access in the EU, Americas and Asia-Pacific for devices and combination products in ophthalmology, orthopedic and aesthetic medicine. Arkan is lecturer and trainer at the University of Applied Sciences in Lower Austria and on life cycle conferences and trainings. He is fluent in English, German, French and Turkish.
Daniel Delfosse
Daniel Delfosse, Dr.sc.techn., is Vice-Director and Head of Regulation & Innovation at the industry association Swiss Medtech. His mantra is “innovation despite regulation” and he pursues the goal of keeping Switzerland an attractive location for the medtech industry.
Daniel graduated from ETH Zurich as a materials engineer and did his doctorate at EPF Lausanne. After a research stay at the University of British Columbia in Vancouver, Canada, he moved to the medtech industry. For almost 20 years he worked as head of development and member of the executive board for a Swiss orthopaedics company, always at the crossroads between regulation and innovation
Elizabeth Gfoeller
Elizabeth Gfoeller is the Corporate Director of Regulatory Affairs of MED-EL, an EU medical device manufacturer headquartered in Innsbruck, Austria.
Joining MED-EL in 2006, she currently leads the Corporate Regulatory Affairs function which has global responsibility for product licensing, registrations, re-certifications, post-market vigilance activities, regulatory strategies for new product developments and related compliance activities internally within MED-EL and externally to new and changed regulations and standards.
William Lory
William Lory, Pharm. D. is Regulatory Affairs Manager EMEA at Sirtex Medical whose mission is to improve the quality and longevity of patients’ lives by providing innovative interventional oncology solutions. 10+ years of experience in medical device regulatory affairs with multiple submissions at global scale and more specifically according to the Medical Device Regulation (EU) 2017/745.
Amra Racic
Amra is the Sr. Director of Global Government Strategy for MedTech at Veeva Systems. She has been in the Healthcare Industry for over 23 years, and most of those spent in large medical device companies in a variety of regulatory roles. In addition to Abbott and Bayer, she spent 13 years at Medtronic working on global regulatory advocacy, global strategy and global regulatory intelligence, which allowed her to represent the organization in a number of external working groups and hold various chair, co-chair and SME roles.
Contacts
Valeria Quintily
Sr. Scientific Project Manager
valeria.quintily@lsacademy.com
Ilaria Butta
Events and Training Manager
ilaria.butta@lsacademy.com
Registration Fee
€ 670,00 Early Bird fee until 09 September 2024
€ 790,00 Ordinary fee
€ 430,00 Freelance, Individual, Academy, Public Administration
Fee includes: seat at the conference, pdf copy of presentations of Speakers who allow the distribution, networking lunch, coffee breaks, organisational office assistance, certificate of attendance.
Useful Information
The conference will take place at:
Hotel Scandic Copenhagen
Vester Søgade 6, Copenhagen – Denmark
Centrally located, 500 metres from Copenhagen Central Station, this contemporary hotel offers stunning views of the lakes and the Copenhagen skyline. From Copenhagen Airport: only 12 km by car. By public transport (via metro or bus), journey time around 25-minutes.